Pictet Asset Management Holding SA »

Iovance Biotherapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $48M 3.3M 14.62

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
BlackRock
Perceptive Advisors
venBio Select Advisor
Geode Capital Management
T. Rowe Price Associates
Artisan Partners Limited Partnership
Susquehanna International
Jpmorgan Chase & Co
Goldman Sachs Group
Soleus Capital Management
Voloridge Investment Management
Pictet Asset Management Holding SA
Summit Partners Public Asset Management

View all funds holding Iovance Biotherapeutics